ClinicalTrials.Veeva

Menu

Measurement of the Free Fraction of 25-hydroxyvitamin D in Serum

U

University of Tromso (UiT)

Status

Completed

Conditions

Impaired Glucose Tolerance

Study type

Observational

Funder types

Other

Identifiers

NCT01771380
Tromsø-Endo-2013-1

Details and patient eligibility

About

In the circulation 25-hydroxyvitaminD (25(OH)D) is bound to the vitamin D binding protein (DBP) and albumin. According to the free hormone hypothesis, it is, however, the free fraction that is biologically active. Polymorphisms in DBP are related to the serum level of 25(OH)D. As these polymorphisms may also affect the binding affinities for 25(OH)D, the total serum 25(OH)D may not necessary reflect the free fraction. To test this hypothesis, we will calculate the free fraction of 25(OH)D by correction for DBP and albumin content, and also measure free 25(OH)D from equilibrium dialysis and ultra filtration. Furthermore, we will relate total serum 25(OH)D as well as the free and biologically active (free- albumin-bound) 25(OH)D to the well established vitamin D effect marker serum parathyroid hormone as well as to the RNA expression in peripheral blood to evaluate the biological importance of the free versus the total fraction of 25(OH)D. We will invite 300 subjects from an ongoing vitamin D supplementation study to participate in the study which will be one visit only and include collection of blood samples.

Enrollment

78 patients

Sex

All

Ages

25 to 85 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Impaired glucose tolerance
  • living in the Tromsø area

Exclusion Criteria

  • pregnancy
  • serious illness

Trial design

78 participants in 1 patient group

Subjects with impaired glucose tolerance

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems